| Code | 96249 | ||||||||||
| MA number | 33/0070/06-S | ||||||||||
| Product Form: | tbl 4x100 mg (blis.Al/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
| Therapeutic Class: | 33 - ANTIMIGRAENICA,ANTISEROTONICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Container: | blister Al/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 10.02.2006 |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Sumatriptan Sandoz tablety_02.2021.doc
|
| PIL: |
PIL_Sumatriptan Sandoz tablety_02.2022.pdf
|
| Safety feature | Yes |
| Data update: | 25.06.2019 |
